Eos Management L.P. Has $4 Million Stock Position in Waters Co. (NYSE:WAT)

Eos Management L.P. boosted its holdings in Waters Co. (NYSE:WAT) by 31.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,790 shares of the medical instruments supplier’s stock after buying an additional 2,589 shares during the quarter. Waters makes up 1.7% of Eos Management L.P.’s holdings, making the stock its 14th biggest holding. Eos Management L.P.’s holdings in Waters were worth $4,003,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of WAT. Kennebec Savings Bank acquired a new position in shares of Waters during the third quarter worth $33,000. Bank of Jackson Hole Trust bought a new stake in Waters during the 4th quarter worth $34,000. Fortitude Family Office LLC increased its holdings in Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC raised its position in Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 53 shares during the last quarter. Finally, Ashton Thomas Securities LLC acquired a new stake in shares of Waters during the third quarter valued at about $35,000. Institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on WAT shares. JPMorgan Chase & Co. upped their price objective on Waters from $380.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. Sanford C. Bernstein upgraded shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target for the company in a research report on Friday, January 10th. StockNews.com lowered shares of Waters from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Barclays upgraded Waters from an “underweight” rating to an “equal weight” rating and increased their price objective for the company from $360.00 to $415.00 in a report on Monday, February 10th. Finally, Scotiabank raised Waters from a “sector perform” rating to a “sector outperform” rating and lifted their target price for the stock from $430.00 to $450.00 in a report on Thursday, February 13th. Eleven analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Waters currently has an average rating of “Hold” and an average target price of $391.07.

Waters Stock Performance

Shares of WAT stock opened at $390.52 on Tuesday. The firm has a 50 day moving average of $391.02 and a 200-day moving average of $369.52. The company has a market cap of $23.20 billion, a price-to-earnings ratio of 36.46, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56.

Waters (NYSE:WAT) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. On average, equities analysts forecast that Waters Co. will post 12.86 earnings per share for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.